Emory University - Microbiology and Molecular Genetics Program; Emory University - Emory Vaccine Center; Emory University - Yerkes National Primate Research Center
Emory University - Emory Vaccine Center; Emory University - Yerkes National Primate Research Center; Emory University - Division of Infectious Diseases
Emory University - Microbiology and Molecular Genetics Program; Emory University - Emory Vaccine Center; Emory University - Yerkes National Primate Research Center
Emory University - Microbiology and Molecular Genetics Program; Emory University - Emory Vaccine Center; Emory University - Yerkes National Primate Research Center
Emory University - Microbiology and Molecular Genetics Program; Emory University - Emory Vaccine Center; Emory University - Yerkes National Primate Research Center; Emory University - Division of Infectious Diseases
Beyond defense against foreign DNA, the CRISPR-Cas9 system of pathogenic Francisella novicida represses expression of an endogenous immunostimulatory lipoprotein and is essential for virulence. We investigated the specificity and molecular mechanism of this regulation, demonstrating that Cas9 has a highly specific regulon of four genes which must be repressed for bacterial virulence. Regulation occurs through a PAM-dependent interaction of Cas9 with its endogenous DNA targets, directed by a non-canonical small RNA (scaRNA) duplexed with tracrRNA. The limited complementarity between scaRNA and the endogenous DNA targets precludes cleavage. This highlights the evolution of the scaRNA to direct transcriptional interference via interaction with endogenous DNA without lethally targeting the chromosome. We show that scaRNA can be reprogrammed to repress other genes, and with engineered, extended complementarity to an exogenous target, the repurposed scaRNA:tracrRNA-Cas9 machinery can also be licensed to direct cleavage of target DNA. Natural Cas9 transcriptional interference likely represents a broad paradigm of regulatory functionality, which is potentially critical to the physiology of numerous Cas9-encoding pathogenic and commensal organisms.
Ratner, Hannah K. and Escalera-Maurer, Andrés and Le Rhun, Anaïs and Jaggavarapu, Siddarth and Wozniak, Jessie E. and Crispell, Emily K. and Charpentier, Emmanuelle and Weiss, David S., Catalytically Active Cas9 Mediates Transcriptional Interference to Facilitate Bacterial Virulence (April 16, 2019). Available at SSRN: https://ssrn.com/abstract=3372971 or http://dx.doi.org/10.2139/ssrn.3372971
This version of the paper has not been formally peer reviewed.
Subscribe to this free journal for more curated articles on this topic
FOLLOWERS
21
PAPERS
9,962
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.